Effects of ozone on lung function and lung diseases

Current Opinion in Pulmonary Medicine

Volumn 9, Issue 2, 2003, Pages 144-150

  Uysal, Nevin ^a   Schapira, Ralph M ^a  

^a CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITROGEN; OZONE; VOLATILE ORGANIC COMPOUND;

BRONCHUS HYPERREACTIVITY; ENVIRONMENTAL EXPOSURE; HUMAN; LONG TERM EXPOSURE; LUNG DISEASE; LUNG FUNCTION; LUNG INJURY; PARTICULATE MATTER; PNEUMONIA; REVIEW; STANDARD;

AIR POLLUTANTS; ANIMALS; CLINICAL TRIALS; ENVIRONMENTAL EXPOSURE; HUMANS; LUNG DISEASES; OZONE; RESPIRATORY FUNCTION TESTS; UNITED STATES; UNITED STATES ENVIRONMENTAL PROTECTION AGENCY;

EID: 0037365055     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-200303000-00009     Document Type: Review

References (108)

1. Bascom R, Bromberg PA, Costa DA, et al: American Thoracic Society, Committee of the Environmental and Occupational Health Assembly, health effects of outside air pollution, part I. Am J Respir Crit Care Med 1996, 153:3-50.
2. Abbey DE, Nishino N, McDonnell WF, et al: Long-term inhalable particles and other air pollutants related to mortality in nonsmokers. Am J Respir Crit Care Med 1999, 159:373-382.
3. Delfino RJ, Murphy-Moulton AM, Burnett RT, et al: Effects of air pollution on emergency room visits for respiratory illness in Montreal, Quebec. Am J Respir Crit Care Med 1997, 155:568-576.
4. Abbey DE, Burchette RJ, Knutsen SF, et al: Long-term particulate and other air pollutants and lung function in nonsmokers. Am J Respir Crit Care Med 1998, 158:289-298.
5. Ozone nonattainment areas [Environmental Protection Agency Web site]. January 1, 2002. Available at: http://www.epa.gov/oar/oaqps/greenbk/onstate.html and http://www.epa.gov/oar/oaqps/greenbk/onmapc.html. Accessed September 17, 2002.
6. National ambient air quality standards [Environmental Protection Agency Web site]. August 19, 2002. Available at: http://www.epa.gov/airs/criteria.html. Accessed September 23, 2002.
7. Environmental news-Headquarters press release: February 27, 2001 and March 26, 2002. Environmental Protection Agency Web site]. Available at: http://yosemite.epa.gov/opa/admpress.nsf. Accessed September 23, 2002.
8. Samet J, Buist S, Bascom R, et al: American Thoracic Society, Committee of the Environmental and Occupational Health Assembly, What constitutes an adverse health effect of air pollution? Am J Respir Crit Care Med 2000, 161:665-673.
9. Toward TJ, Broadley KJ: Airway function, oedema, cell infiltration and nitric oxide generation in conscious ozone-exposed guinea pigs: effects of dexamethasone and rolipram. Br J Pharmacol 2002, 136:735-745.
10. Inoue H, Aizawa H, Nakano H, et al: Nitric oxide synthase inhibitors attenuate ozone-induced airway inflammation in guinea pigs. Am J Respir Care Med 2000, 161:249-256.
11. Fakhrzadeh L, Laskin JD, Laskin DL: Deficiency in inducible nitric oxide synthase protects mice from ozone-induced lung inflammation and tissue injury. Am J Respir Cell Mol Biol 2002, 26:413-419.
12. Kenyon NJ, Van Der Vliet A, Schock BC, et al: Susceptibility to ozone-induced acute lung injury iNOS-deficient mice. Am J Physiol Lung Cell Mol Physiol 2002, 282:L540-L545.
13. Stevens WHM, Vanderheyden C, Wattie J, et al: Effect of a leukotriene B4 receptor antagonist SC-53228 on ozone-induced airway hyperresponsiveness and inflammation in dogs. Am J Respir Crit Care Med 1995, 152:1443-1448.
14. Koto H, Salmon M, Haddad E, et al: Role of cytosine-induced neutrophil chemoattractant (CINC) in ozone-induced airway inflammation and hyperresponsiveness. Am J Respir Crit Care Med 1997, 156:234-239.
15. Shore SA, Schwartzman IN, Le Blank B, et al: Tumor necrosis factor receptor 2 contributes to ozone-induced airway hyperresponsiveness in mice. Am J Respir Crit Care Med 2001, 164:602-607.
16. Igarashi A, Iijima H, Tamura G, et al: Tazanoplast inhibits ozone-induced airway hyperresponsiveness in guinea pigs. Am J Respir Crit Care Med 1998, 157:1531-1535.
17. 3-induced hyperresponsiveness. J Appl Physiol 2001, 91:2595-2601.
18. Long NC, Suh J, Morrow JD, et al: Ozone causes lipid per oxidation but little antioxidant depletion in exercising and nonexercising hamsters. J Appl Physiol 2001, 91:1694-1700.
19. Plopper CG, Hatch GE, Wong V, et al: relation of inhaled ozone concentration to acute tracheobronchial epithelial injury, site-specific ozone-dose, and glutathione depletion in rhesus monkeys. Am J Respir Cell Mol Biol 1998, 19:387-399.
20. 2 receptor activation mediate ozone-induced increase in the permeability of the tracheal mucosa in guinea pigs. Br J Pharmacol 2002, 135:1331-1335.
21. Michalec L, Choudhury BK, Postlethwait E, et al: CCL7 and CXCL10 orchestrate oxidative stress-induced neutrophilic lung inflammation. J Immunol 2002, 168:846-852.
22. Fievez L, Kirschvink N, Dogne S, et al: Impaired accumulation of granulocytes in the lung during ozone adaptation. Free Radic Biol Med 2001, 31:633-641.
23. Cho HY, Hotchkiss JA, Bennet CB, et al: Neutrphil-dependent and neutrophil independent alterations in the nasal epithelium of ozone-exposed rats. Am J Respir Crit Care Med 2000, 162:629-636.
24. Salmon M, Koto H, Lynch OT, et al: Proliferation of airway after ozone exposure. Am J Respir Crit Care Med 1998, 157:970-977.
25. Yamauchi T, Shima M, Kuwaki T, et al: Acute effects of ozone exposure on lung function in mice sensitized to ovalbumin. Toxicology 2002, 172:69-78.
26. Yu M, Pinkerton KE, Witschi H: Short-term exposure to aged and diluted sidestream cigarette smoke enhances ozone-induced lung injury in B6C3F1 mice. Toxicol Sci 2002, 65:99-106.
27. Kim MY, Son JW, Cho MH, et al: Oviductal carcinoma in B6C3F1 female mice exposed to 0.5 ppm ozone. Vet Human Toxicol 2001, 43:370-372.
28. Costa DL, Tepper JS, Stevens MA, et al: Restrictive lung disease in rats exposed chronically to an urban profile of ozone. Am J Respir Crit Care Med 1995, 151:1512-1518.
29. Kinney PL, Nilsen DM, Lippmann M, et al: Biomarkers of lung inflammation in recreational joggers exposed to ozone. Am J Respir Crit Care Med 1996, 154:1430-1435.
30. Balmes JR, Chen LL, Scannell C, et al: Ozone-induced decrements in FEV1 and FVC do not correlate with measures of inflammation. Am J Respir Crit Care Med 1996, 153:904-909.
31. Bassett D, Elbon-Copp C, Otterbein S, et al: Inflammatory cell availability affects ozone-induced lung damage. J Toxicol Environ Health A 2001, 64:547-565.
32. Krishna MT, Blomberg A, Biscione GL, et al: Short-term ozone exposure upregulates P-selectin in normal human airways. Am J Respir Crit Care Med 1997, 155:1798-1803.
33. Nightingale JA, Rogers DF, Chung KF, et al: No effect of inhaled budenoside on the response to inhaled ozone in normal subjects. Am J Respir Crit Care Med 2000, 161:479-486.
34. Vagaggini B, Taccola M, Conti I, et al: Budesonide reduces neutrophilic but not functional airway response to ozone in mild asthmatics. Am J Respir Crit Care Med 2001, 164:2172-2176.
35. Roy S, Ray MR, Basu C, et al: Abundance of siderophages in sputum- Indicator for an adverse lung reaction to air pollution. Acta Cytologica 2001, 45:958-964.
36. Frampton MW, Pryor WA, Cueto R, et al: Ozone exposure increases aldehydes in epithelial lining fluid in human lung. Am J Respir Crit Care Med 1999, 159:1134-1137.
37. Kafoury RM, Pryor WA, Squadrito GL, et al: Induction of inflammatory mediators in human airway epithelial cells by lipid ozonation products. Am J Respir Crit Care Med 1999, 160:1934-1942.
38. Avissar NE, Reed CK, Cox C, et al: Ozone, but not nitrogen dioxide, exposure decreases glutathione peroxidases in epithelial lining fluid of human lung. Am J Respir Crit Care Med 2000, 162:1342-1347.
39. Mudway IA, Stenfors N, Blomberg A, et al: Differences in basal airway antioxidant concentrations are not predictive of individual responsiveness to ozone: A comparison of healthy and mild asthmatic subjects. Free Radic Biol Med 2001, 31:962-974.
40. Kumarathasan P, Vincent R, Goegan P, et al: Hydroxyl radical adduct of 5-aminosalicylic acid: A potential marker of ozone-induced oxidative stress. Biochem Cell Biol 2001, 79:33-42.
41. Liu L, Leech JA, Urch B, et al: In vivo salicylate hydroxylation: A potential biomarker for assessing acute ozone exposure and effects in humans. Am J Respir Crit Care Med 1997, 156:1405-1412.
42. Romieu I, Meneses F, Ramirez M, et al: Antioxidant supplementation and respiratory functions among workers exposed to high levels of ozone. Am J Respir Crit Care Med 1998, 158:226-232.
43. Grievink L, Zijlstra AG, Ke X, et al: Double-blind intervention trial on modulation of ozone effects on pulmonary function by antioxidant supplements. Am J Epidemiol 1999, 149:306-314.
44. Samet JM, Hatch GE, Horstman D, et al: Effect of antioxidant supplementation on ozone-induced lung injury in human subjects. Am J Respir Crit Care Med 2001, 164:819-825.
45. Lee L-Y, Widdicombe JG: Modulation of airway sensitivity to inhaled irritants: Role of inflammatory mediators. Environ Health Perspect 2001, 109(suppl 4):585-589.
46. Krishna MT, Springall D, Meng Q-H, et al: Effects of ozone on epithelium and sensory nerves in the bronchial mucosa of healthy humans. Am J Respir Crit Care Med 1997, 156:943-950.
47. Schelegle ES, Eldridge MW, Cross CE, et al: Differential effects of airway anesthesia on ozone-induced pulmonary responses in human subjects. Am J Respir Crit Care Med 2001, 163:1121-1127.
48. Holz O, Jorres RA, Timm P, et al: Ozone-induced airway inflammatory changes differ between individuals and are reproducible. Am J Respir Crit Care Med 1999, 159:776-784.
49. Bergamaschi E, De Palma G, Mozzoni P, et al: Polymorphism of quinone-metabolizing enzymes and susceptibility to ozone-induced acute defects. Am J Respir Crit Care Med 2001, 163:1426-1431.
50. Wang G, Umstead TM, Phelps DS, et al: The effects of ozone exposure on the ability of human surfactant protein A variants to stimulate cytokine production. Environ Health Perspect 2002, 110:79-84.
51. 1 changes. Am J Respir Crit Care Med 1997, 156:715-722.
52. Torres A, Utell MJ, Morow PE, et al: Airway inflammation in smokers and non-smokers with varying responsiveness to ozone. Am J Respir Crit Care Med 1997, 156:728-736.
53. Frampton MW, Morrow PE, Torres A, et al: Ozone responsiveness in smokers and nonsmokers. Am J Respir Crit Care Med 1997;155:116-121.
54. Gong H Jr, Wong R, Sarma RJ, et al: Cardiovascular effects of ozone exposure in human volunteers. Am J Respir Crit Care Med 1998, 158:538-546.
55. Jenkins HS, Devalia JL, Mister RL, et al: The effect of exposure to ozone and nitrogen dioxide on the airway response of atopic asthmatics to inhaled allergen. Am J Respir Crit Care Med 1999, 160:33-39.
56. Peden DB, Setzer RW Jr, Devlin RB, et al: Ozone exposure has both a priming effect on allergen-induced responses and an intrinsic inflammatory action in the nasal airways of perennially allergic asthmatics. Am J Respir Crit Care Med 1995, 151:1336-1345.
57. Scannell C, Chen L, Aris RM, et al: Greater ozone-induced inflammatory responses in subjects with asthma. Am J Respir Crit Care Med 1996, 154:24-29.
58. Jorres R, Nowak D, Magnussen H, et al: The effect of ozone exposure on allergen responsiveness in subjects with asthma or rhinitis. Am J Respir Crit Care Med 1996, 153:56-64.
59. Linn WS, Anderson KR, Shamoo DA, et al: Controlled exposures of young asthmatics to mixed oxidant gases and acid aerosol. Am J Respir Crit Care Med 1995, 152:885-891.
60. Hanania NA, Tarlo SM, Silverman F, et al: Effect of exposure to low levels of ozone on the response to inhaled allergen in allergic asthmatic patients. Chest 1998, 114:752-756.
61. Linn WS, Shamoo DA, Venet TG, et al: Response to ozone in volunteers with chronic obstructive pulmonary disease. Arch Environ Health 1983, 38:278-283.
62. Gong H Jr, Shamoo DA, Anderson KR, et al: Responses of older men with and without chronic obstructive pulmonary disease to prolonged ozone exposure. Arch Environ Health 1997, 52:18-25.
63. McDonnell WF, Horstman DH, Hazucha MJ, et al: Pulmonary effects of ozone exposure during exercise: dose-response characteristics. J Appl Physiol 1983, 54:1345-1352.
64. Gong H Jr, Bradley PW, Simmons MS, et al: Impaired exercise performance and pulmonary function in elite cyclists during low-level ozone exposures in a hot environment. Am Rev Respir Dis 1986, 134:726-733.
65. Horstman DH, Folinsbee LJ, Ives PJ, et al: Ozone concentrations and pulmonary response relationships for 6.6-hour exposures with five hours of moderate exercise to 0.08, 0.10, and 0.12 ppm. Am Rev Respir Dis 1990, 142:1158-1163.
66. McDonnell WF, Kehrl HR, Abdul-Salaam S, et al: Respiratory response of humans exposed to low levels of ozone for 6.6 hours. Arch Environ Health 1991, 46:145-150.
67. McDonnell WF, Stewart PW, Andreoni S, et al: Proportion of moderately exercising individuals responding to low-level, multi-hour ozone exposure. Am J Respir Crit Care Med 1995, 152:589-596.
68. Castillejos M, Gold DR, Damokosh AI, et al: Acute effects of ozone on the pulmonary function of exercising schoolchildren from Mexico City. Am J Respir Crit Care MEd 1995, 152:1501-1507.
69. Spektor DM, Lippmann M, Thurston GD, et al: Effects of ambient ozone on respiratory function in healthy adults exercising outdoors. Am Rev Respir Dis 1988, 138:821-828.
70. Korrick SA, Neas LM, Dockery DW, et al: Effects of ozone and other pollutants on the pulmonary function of adult hikers. Environ Health Perspect 1998, 106:93-99.
71. Brauer M, Blair J, Vedal S: Effect of ambient ozone exposure on lung function in farm workers. Am J Respir Crit Care Med 1996, 154:981-987.
72. Christian DL, Chen LL, Scannell OH, et al: Ozone-induced inflammation is attenuated with multiday exposure. Am J Respir Crit Care Med 1998, 158:532-537.
73. Jorres RA, Holz O, Zachgo W, et al: The effect of repeated ozone exposures on inflammatory markers in bronchoalveolar lavage fluid and mucosal biopsies. Am J Respir Crit Care ed 2000, 161:1855-1861.
74. 3 for 2 hours on 4 consecutive days. Persistent change was confined to measures of small airway function and to rapid shallow breathing.
75. Kinney PL, Ozkaynak H: Associations of daily mortality and air pollution in Los Angeles County. Environ Res 1991, 54:99-120.
76. Anderson HR, Ponce de Leon A, Bland JM, et al: Air pollution and daily mortality in London: 1987-1992. BMJ 1996, 312:665-669.
77. Borja-Aburto VH, Loomis DP, Bangdiwala SI, et al: Ozone, suspended particulates, and daily mortality in Mexico City. Am J Epidemiol 1997, 145:258-268.
78. Beeson WL, Abbey DE, Knutsen SF: Long-term concentrations of ambient air pollutants and incident lung cancer in California adults: results from the AHSMOG study. Environ Health Perpect 1998, 106:813-823.
79. Shwartz J: Short term fluctuations in air pollution and hospital admissions of the elderly for respiratory disease. Thorax 1995, 50:531-538.
80. Stieb DM, Burnett RT, Beveridge RC, et al: Association between ozone and asthma emergency department visits in Saint John, New Brunswick, Canada. Environ Health Perspect 1996, 104:1354-1360.
81. Buchdahl R, Parker A, Stebbings T, et al: Association between air pollution and acute childhood wheezy episodes: prospective observational study. BMJ 1996, 312:661-665.
82. Stedman JR, Anderson HR, Atkinson RW, et al: Emergency hospital admissions for respiratory disorders attributable to summer time ozone episodes in Great Britain. Thorax 1997, 52:958-963.
83. Castellsague J, Sunyer J, Saez M, et al: Short-term association between air pollution and emergency room visits for asthma in Barcelona. Thorax 1995, 50:1051-1056.
84. Sunyer J, Spix C, Quenel P et al: Urban air pollution and emergency admissions for asthma in four European cities: the APHEA project. Thorax 1997, 52:760-765.
85. Hajat S, Haines A, Goubet SA, et al: Association of air pollution with daily GP consultations for asthma and other lower respiratory conditions in London. Thorax 1999, 54:597-605.
86. Atkinson RW, Anderson HR, Sunyer J, et al: Acute effects of particulate air pollution on respiratory admissions: results from APHEA 2 project. Am J Respir Crit Care Med 2001, 164:1860-1866.
87. Higgins BG, Francis HC, Yates CJ, et al: Effects of air pollution on symptoms and peak expiratory flow measurements in subjects with obstructive airways disease. Thorax 1995, 50:149-155.
88. Delfino RJ, Coate BD, Zeiger RS, et al: Daily asthma severity in relation to personal ozone exposure and outdoor fungal spores. Am J Respir Crit Care Med 1996, 154:633-641.
89. Romieu I, Meneses F, Ruiz S, et al: Effects of air pollution on the respiratory health of asthmatic children living in Mexico City. Am J Respir Crit Care Med 1996, 154:300-307.
90. Gielen MH, van der Zee SC, van Wijnen JH, et al: Acute effects of summer air pollution on respiratory health of asthmatic children. Am J Respir Crit Care Med 1997, 155:2105-2108.
91. Hiltermann TJN, de Bruijne CR, Stolk J, et al: Effects of photochemical air pollution and allergen exposure on upper respiratory tract inflammation in asthmatics. Am J Respir Crit Care Med 1997, 156:1765-1772.
92. Sunyer J, Basagana X, Belmonte J, et al: Effect of nitrogen dioxide and ozone on the risk of dying in patients with severe asthma. Thorax 2002, 57:687-693. This study provides for the first time an analysis of the acute effects of air pollution on mortality in subjects with severe asthma. In this study, ozone increased the risk of death in asthmatic patients (OR = 1.90, 95% CI 1.09 to 3.30).
93. Mortimer KM, Tager IB, Dockery DW, et al: The effect of ozone on inner-city children with asthma: identification of susceptible subgroups. Am J Respir Crit Care Med 2000, 162:1838-1845.
94. Cassino C, Ito K, Bader I, et al: Cigarette smoking and ozone-associated emergency department use for asthma by adults in New York City. Am J Respir Crit Care Med 1999, 159:1773-1779.
95. Kunzli N, Lurmann F, Segal M, et al: Association between lifetime ambient ozone exposure and pulmonary function in college freshmen - Results of a pilot study. Environ Research 1997, 72:8-23.
96. Peters JM, Avol E, Navidi W, et al: A study of twelve Southern Californian communities with differing levels and types of air pollution. I. Prevalence of respiratory morbidity. Am J Respir Crit Care Med 1999, 159:760-767.
97. Peters JM, Avol E, Gauderman WJ, et al: A study of twelve Southern Californian communities with differing levels and types of air pollution. II. Effects on pulmonary function. Am J Respir Crit Care Med 1999, 159:768-775.
98. Hodgkin JE, Abbey DE, Euler GL, et al: COPD prevalence in nonsmokers in high and low photochemical air pollution areas. Chest 1984, 86:830-838.
99. Euler GL, Abbey DE, Hodgkin JE, et al: Chronic obstructive pulmonary disease symptom effects of long-term cumulative exposure to ambient levels of total oxidants and nitrogen dioxide in California Seventh-day Adventist residents. Arch Environ Health 1988, 43:279-285.
100. Kinney PL, Thurston GD, Raizenne Mark, et al: The effects of ambient ozone on lung function in children: a reanalysis of six summer camp studies. Environ Health Perspect 1996, 104:170-174.
101. Scarlett JF, Abbott KJ, Peacock JL, et al: Acute effects of summer air pollution on respiratory function in primary school children in southern England. Thorax 1996, 51:1109-1114.
102. Braun-Fahrlander C, Vuille JC, Sennhauser FH, et al: Respiratory health and long-term exposure to air pollutants in Swiss schoolchildren. Am J Respir Crit Care Med 1997, 155:1042-1049.
103. Frischer T, Studnicka M, Gartner C, et al: Lung function growth and ambient ozone. Am J Respir Crit Care Med 1999, 160:390-396.
104. Gauderman WJ, McConnell R, Gilliland F, et al: Association between air pollution and lung function growth in southern California children. Am J Respir Crit Care Med 2000, 162:1383-1390.
105. Avol EL, Gauderman WJ, Tan SM, et al: Respiratory effects of relocating to areas of differing air pollution levels. Am J Respir Crit Care Med 2001, 164:2067-2072. Avol et al. studied 110 children who had moved from communities participating in a 10-year prospective study of respiratory health to determine whether changes in air quality caused by relocation were associated with changes in annual lung function growth rates. Changes in annual average exposure to particulates, not ozone, were associated with differences in annual lung function growth rates.
106. Gauderman WJ, Gilliland GF, Vora H, et al: Association between air pollution and lung function in Southern California children. Results from a second cohort. Am J Respir Crit Care Med 2002, 166:76-84. A cohort of 1,678 Southern Californian children was followed for 4 years to determine whether the growth in lung function of the children was associated with their exposure to ambient air pollutants. Exposure to ozone was associated with only reduced growth in peak flow rate.
107. Thurston GD: A reanalysis of the ozone and asthma relationship. Am J Respir Crit Care Med 1998, 158:341-342.
108. Tager IB: Air pollution and lung function growth. Is it ozone? Am J Respir Crit Care Med 1999, 160:387-389.